{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:13:34Z","timestamp":1778001214867,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"DOI":"10.7759\/cureus.108306","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:26:51Z","timestamp":1777998411000},"source":"Crossref","is-referenced-by-count":0,"title":["Phentermine-Induced Dilated Cardiomyopathy: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Salomon","family":"Chamay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darya","family":"Chekhava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrunalini","family":"Dandamudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01408-z","article-title":"Association of obesity with cardiovascular disease in the absence of traditional risk factors","volume":"48","author":"Luo H","year":"2024","unstructured":"Luo H, Liu Y, Tian X, et al.. Association of obesity with cardiovascular disease in the absence of traditional risk factors. Int J Obes (Lond). 2024, 48:263-70. 10.1038\/s41366-023-01408-z","journal-title":"Int J Obes (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114521000064","article-title":"Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies","volume":"126","author":"Xue R","year":"2021","unstructured":"Xue R, Li Q, Geng Y, Wang H, Wang F, Zhang S. Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies. Br J Nutr. 2021, 126:1420-30. 10.1017\/S0007114521000064","journal-title":"Br J Nutr"},{"key":"ref3","article-title":"Valvular heart disease with the use of fenfluramine-phentermine","volume":"38","author":"Surapaneni P","year":"2011","unstructured":"Surapaneni P, Vinales KL, Najib MQ, Chaliki HP. Valvular heart disease with the use of fenfluramine-phentermine. Tex Heart Inst J. 2011, 38:581-3.","journal-title":"Tex Heart Inst J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2037","article-title":"Anti-obesity therapies","volume":"5","author":"Melnikova I","year":"2006","unstructured":"Melnikova I, Wages D. Anti-obesity therapies. Nat Rev Drug Discov. 2006, 5:369-70. 10.1038\/nrd2037","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1192022","article-title":"Fenfluramine: a plethora of mechanisms?","volume":"14","author":"Sourbron J","year":"2023","unstructured":"Sourbron J, Lagae L. Fenfluramine: a plethora of mechanisms?. Front Pharmacol. 2023, 14:1192022. 10.3389\/fphar.2023.1192022","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.12.009","article-title":"Drugs and medical devices: adverse events and the impact on women's health","volume":"39","author":"Carey JL","year":"2017","unstructured":"Carey JL, Nader N, Chai PR, Carreiro S, Griswold MK, Boyle KL. Drugs and medical devices: adverse events and the impact on women's health. Clin Ther. 2017, 39:10-22. 10.1016\/j.clinthera.2016.12.009","journal-title":"Clin Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly HM","year":"1997","unstructured":"Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997, 337:581-8. 10.1056\/NEJM199708283370901","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370911","article-title":"Further cases of valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Graham DJ","year":"1997","unstructured":"Graham DJ, Green L. Further cases of valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997, 337:635. 10.1056\/NEJM199708283370911","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde KM","year":"2011","unstructured":"Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011, 377:1341-52. 10.1016\/S0140-6736(11)60205-5","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMclde1515935","article-title":"Obesity and management of weight loss","volume":"375","author":"Yeh JS","year":"2016","unstructured":"Yeh JS, Kushner RF, Schiff GD. Obesity and management of weight loss. N Engl J Med. 2016, 375:1187-9. 10.1056\/NEJMclde1515935","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.007","article-title":"Cardiovascular effects of the new weight loss agents","volume":"68","author":"Vorsanger MH","year":"2016","unstructured":"Vorsanger MH, Subramanyam P, Weintraub HS, et al.. Cardiovascular effects of the new weight loss agents. J Am Coll Cardiol. 2016, 68:849-59. 10.1016\/j.jacc.2016.06.007","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31114","article-title":"A rare case of phentermine-induced nonischemic cardiomyopathy","volume":"14","author":"Damani D","year":"2022","unstructured":"Damani D, Hassan M, Mahapatra S, et al.. A rare case of phentermine-induced nonischemic cardiomyopathy. Cureus. 2022, 14:e31114. 10.7759\/cureus.31114","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey WT","year":"2012","unstructured":"Garvey WT, Ryan DH, Look M, et al.. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012, 95:297-308. 10.3945\/ajcn.111.024927","journal-title":"Am J Clin Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391392-phentermine-induced-dilated-cardiomyopathy-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:26:52Z","timestamp":1777998412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391392-phentermine-induced-dilated-cardiomyopathy-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.108306","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}